Figure S1. Differentiation capacity and expression of membranous markers of MSCs. Representative examples are shown (40Ă magnification). A, chondrogenic differentiation was performed using cell pellet cultures and assessed using toluidine blue staining. Adipogenic differentiation was assessed using phase contrast microscopy (B) and Oil-red-O staining (C). Osteogenic differentiation was assessed using phase contrast microscopy (D) and Alizarin red staining (E). F, all samples expressed CD73, CD90 and CD105 (bold histograms) as determined by flow cytometry (isotype controle staining shown for comparison)
Figure S2. The osteogenic, adipogenic, and chondrogenic differentiation of ADSCs. After ADSCs were c...
Morphology of DiI-labeled MSCs in co-culture with unlabeled OBCs. Images of MSCs on culture days 6 a...
Figure S2. CYR61 controls osteosarcoma cell phenotype in vitro. (A) Morphology of K7 M2 and U2OS ost...
Supplemental figures. Figure S1: Analysis of MSC phenotypic markers by flow cytometry. Figure S2: An...
Figure S1. Differentiation of MSCs into osteocytes, adipocytes, and chondrocytes. MSCs were induced ...
Supplemental methods. Methods used for analysis of MSC phenotypic markers and differentiation. (DOCX...
Figure S1. Characterization of bone-marrow derived MSCs. (a) As assessed by flow cytometry, MSCs wer...
Figure S2. Quantification of Alizarin Red staining in upper and lowest layers. haMSCs were cultured ...
Figure S1. Flow cytometric immunophenotyping data of MSCs. MSCs positive for CD29 (99.5%), CD44 (99....
Trilineage differentiation of bone marrow derived MSCs. Control samples cultured in growth medium an...
Cell surface markers and differentiation capacities of mouse MSCs. (A) Flow cytometry analysis resul...
Table S1. List of primers used for qRT-PCR. Table S2. Full osteogenic gene expression list (total 84...
Figure S2. Identification of BMSCs. a Typical surface marker for the P6 and P10 BMSCs was detected u...
Figure S1. showing identification of hMSCs. (A) Morphological appearance of third-passage hMSCs. Sca...
Multipotent differentiation capacity of SCs. CD271+ and CD271− synovial SCs were cultured under spec...
Figure S2. The osteogenic, adipogenic, and chondrogenic differentiation of ADSCs. After ADSCs were c...
Morphology of DiI-labeled MSCs in co-culture with unlabeled OBCs. Images of MSCs on culture days 6 a...
Figure S2. CYR61 controls osteosarcoma cell phenotype in vitro. (A) Morphology of K7 M2 and U2OS ost...
Supplemental figures. Figure S1: Analysis of MSC phenotypic markers by flow cytometry. Figure S2: An...
Figure S1. Differentiation of MSCs into osteocytes, adipocytes, and chondrocytes. MSCs were induced ...
Supplemental methods. Methods used for analysis of MSC phenotypic markers and differentiation. (DOCX...
Figure S1. Characterization of bone-marrow derived MSCs. (a) As assessed by flow cytometry, MSCs wer...
Figure S2. Quantification of Alizarin Red staining in upper and lowest layers. haMSCs were cultured ...
Figure S1. Flow cytometric immunophenotyping data of MSCs. MSCs positive for CD29 (99.5%), CD44 (99....
Trilineage differentiation of bone marrow derived MSCs. Control samples cultured in growth medium an...
Cell surface markers and differentiation capacities of mouse MSCs. (A) Flow cytometry analysis resul...
Table S1. List of primers used for qRT-PCR. Table S2. Full osteogenic gene expression list (total 84...
Figure S2. Identification of BMSCs. a Typical surface marker for the P6 and P10 BMSCs was detected u...
Figure S1. showing identification of hMSCs. (A) Morphological appearance of third-passage hMSCs. Sca...
Multipotent differentiation capacity of SCs. CD271+ and CD271− synovial SCs were cultured under spec...
Figure S2. The osteogenic, adipogenic, and chondrogenic differentiation of ADSCs. After ADSCs were c...
Morphology of DiI-labeled MSCs in co-culture with unlabeled OBCs. Images of MSCs on culture days 6 a...
Figure S2. CYR61 controls osteosarcoma cell phenotype in vitro. (A) Morphology of K7 M2 and U2OS ost...